A clinical and spirometric trial of a new   receptor stimulant drug, terbutaline, in asthmaic patients.
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002082:Butylamines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000627:therapeutic use*; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use; D012118:Resorcinols / Q000627:therapeutic use; D013147:Spirometry
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D002082:Butylamines; D004983:Ethanolamines; D012118:Resorcinols; D009921:Metaproterenol